Bruker Daltonics and Thermo Finnigan Settle Longstanding Ion Trap Patents Dispute | GenomeWeb

NEW YORK, Aug. 30 – Bruker Daltonics and Thermo Finnigan have reached a settlement agreement in their multi-year, international patent dispute over the companies’ ion trap mass spectrometry technologies, the companies announced Thursday.

As part of the agreement, both companies have agreed to dismiss all pending suits throughout the US and Europe and waive all damages related to the disputes. The agreement also provides a framework of licensing and arbitration for potential future patent disagreements between the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.